These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2428075)

  • 1. Does corticotropin releasing factor act via a calcium-dependent mechanism?
    Aldenhoff JB
    Psychoneuroendocrinology; 1986; 11(2):231-6. PubMed ID: 2428075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons.
    Aldenhoff JB; Gruol DL; Rivier J; Vale W; Siggins GR
    Science; 1983 Aug; 221(4613):875-7. PubMed ID: 6603658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pro-convulsant actions of corticotropin-releasing hormone in the hippocampus of infant rats.
    Hollrigel GS; Chen K; Baram TZ; Soltesz I
    Neuroscience; 1998 May; 84(1):71-9. PubMed ID: 9522363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological effects of sustained delivery of CRF and its receptor agonists in hippocampal slices.
    Rebaudo R; Melani R; Balestrino M; Izvarina N
    Brain Res; 2001 Dec; 922(1):112-7. PubMed ID: 11730708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological actions of corticotropin-releasing factor in the central nervous system.
    Siggins GR; Gruol D; Aldenhoff J; Pittman Q
    Fed Proc; 1985 Jan; 44(1 Pt 2):237-42. PubMed ID: 3155696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase A mediates the modulation of the slow Ca(2+)-dependent K(+) current, I(sAHP), by the neuropeptides CRF, VIP, and CGRP in hippocampal pyramidal neurons.
    Haug T; Storm JF
    J Neurophysiol; 2000 Apr; 83(4):2071-9. PubMed ID: 10758117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotrophin-releasing factor augments the I(H) in rat hypothalamic paraventricular nucleus parvocellular neurons in vitro.
    Qiu DL; Chu CP; Shirasaka T; Tsukino H; Nakao H; Kato K; Kunitake T; Katoh T; Kannan H
    J Neurophysiol; 2005 Jul; 94(1):226-34. PubMed ID: 15800070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection by corticotropin releasing factor during hypoxia in rat brain.
    Fox MW; Anderson RE; Meyer FB
    Stroke; 1993 Jul; 24(7):1072-5; discussion 1075-6. PubMed ID: 8322382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple classes of calcium channels in mouse pituitary tumor cells.
    Richardson UI
    Life Sci; 1986 Jan; 38(1):41-50. PubMed ID: 2417085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin releasing factor antagonist reduces ischemic hippocampal neuronal injury.
    Lyons MK; Anderson RE; Meyer FB
    Brain Res; 1991 Apr; 545(1-2):339-42. PubMed ID: 1860056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nifedipine and verapamil block the memory-facilitating effect of corticotropin-releasing factor in rats.
    Lee EH; Lin WR
    Life Sci; 1991; 48(13):1333-40. PubMed ID: 2002759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noradrenaline blocks potassium conductance in rat dentate granule cells in vitro.
    Haas HL; Rose GM
    Neurosci Lett; 1987 Jul; 78(2):171-4. PubMed ID: 2442675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kainate reduces two voltage-dependent potassium conductances in rat hippocampal neurons in vitro.
    Gho M; King AE; Ben-Ari Y; Cherubini E
    Brain Res; 1986 Oct; 385(2):411-4. PubMed ID: 2430672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors.
    Facci L; Stevens DA; Pangallo M; Franceschini D; Skaper SD; Strijbos PJ
    Neuropharmacology; 2003 Oct; 45(5):623-36. PubMed ID: 12941376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo microdialysis of corticotropin releasing factor (CRF): calcium dependence of depolarization-induced neurosecretion of CRF.
    Gabr RW; Gladfelter WE; Birkle DL; Azzaro AJ
    Neurosci Lett; 1994 Mar; 169(1-2):63-7. PubMed ID: 8047294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of verapamil on the locomotor-activating properties of corticotropin releasing factor (CRF) in the rat.
    Swerdlow NR; Koob GF; Aldenhoff JB
    Psychoneuroendocrinology; 1986; 11(2):237-40. PubMed ID: 3489244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of dendritic differentiation by corticotropin-releasing factor in the developing hippocampus.
    Chen Y; Bender RA; Brunson KL; Pomper JK; Grigoriadis DE; Wurst W; Baram TZ
    Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15782-7. PubMed ID: 15496472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrete local application of corticotropin-releasing factor increases locus coeruleus discharge and extracellular norepinephrine in rat hippocampus.
    Page ME; Abercrombie ED
    Synapse; 1999 Sep; 33(4):304-13. PubMed ID: 10421711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats.
    Sarnyai Z; Höhn J; Szabó G; Penke B
    Life Sci; 1992; 51(26):2019-24. PubMed ID: 1335535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of epileptiform burst discharges in CA3 neurons of rat hippocampal slices by the organic calcium channel blocker, verapamil.
    Aicardi G; Schwartzkroin PA
    Exp Brain Res; 1990; 81(2):288-96. PubMed ID: 2168841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.